Lescol

Fluvastatin, the active ingredient in Lescol, is a statin (HMG‑CoA reductase inhibitor) presented as an oral tablet for oral use. It lowers elevated cholesterol levels and is prescribed for patients with hypercholesterolemia or at risk of cardiovascular disease.

GNH USA supplies Lescol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution. Clients benefit from comprehensive regulatory support and timely delivery across multiple regions efficiently.

Lescol (fluvastatin) is used to manage disorders of lipid metabolism and reduce cardiovascular risk. - Hypercholesterolemia: reduces low‑density lipoprotein (LDL) cholesterol levels. - Hyperlipidemia: lowers total cholesterol and triglycerides. - Cardiovascular risk reduction: helps prevent myocardial infarction and stroke in patients with elevated cholesterol.

Fluvastatin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate pain in the head. - Muscle pain: soreness or weakness in skeletal muscles. - Elevated liver enzymes: mild increase in ALT or AST.

Serious or Rare Side Effects: - Rhabdomyolysis: severe muscle breakdown with risk of kidney injury. - Hepatotoxicity: significant elevation of liver enzymes or hepatitis. - Severe allergic reaction: rash, angioedema or anaphylaxis.

When prescribing fluvastatin, clinicians should consider several safety precautions. - Liver function monitoring: assess hepatic enzymes before initiation and periodically during therapy. - Muscle toxicity vigilance: discontinue if unexplained muscle pain, tenderness or weakness occurs. - Drug interactions review: avoid concomitant use with strong CYP3A4 inhibitors. - Pregnancy contraindication: do not use in pregnant women due to fetal risk. - Renal impairment adjustment: evaluate kidney function and adjust dose if necessary. - Store at ambient temperature: keep tablets in original packaging, protect from moisture and light.

Fluvastatin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): may cause dangerous increases in fluvastatin levels. - Gemfibrozil: combined use raises risk of muscle toxicity. - Cyclosporine: enhances statin exposure and myopathy risk.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): fluvastatin may potentiate anticoagulant effect, monitor INR. - Digoxin: possible increase in serum digoxin concentrations. - Niacin: may increase risk of myopathy when used together.